Literature DB >> 34112635

Lobar expression of SARS-CoV-2 pneumonia.

Diogo Mendes Pedro1,2, Maria Cunha3, Tiago Marques3,4.   

Abstract

Entities:  

Keywords:  COVID-19; infectious diseases

Mesh:

Year:  2021        PMID: 34112635      PMCID: PMC8194330          DOI: 10.1136/bcr-2021-242821

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


× No keyword cloud information.

Description

A 59-year-old man with a personal history of gastritis and pulmonary tuberculosis of the left lung without sequelae 40 years earlier was admitted to the emergency department reporting of high fever (maximum 40°C), dry cough and haemoptysis for the past 5 days. He had been subjected to a SARS-CoV-2 PCR screening test 2 days earlier, with an inconclusive result. Laboratory tests revealed lymphopenia and a mild elevation of hepatic transaminases, lactate dehydrogenase and C reactive protein. The chest X-ray was unremarkable; however, the CT scan revealed a wide area of ground-glass opacity in the right upper lobe (figure 1). The microscopic screening of the sputum was negative for tuberculosis. The patient was diagnosed with COVID-19 after a now-positive PCR result. He had a favourable evolution, with mild disease and neither respiratory distress nor hypoxemia. He was asymptomatic 5 days later and presented a normal chest X-ray and positive SARS-CoV-2 serology after 1 month of follow-up.
Figure 1

CT scan showing upper lobe COVID-19, bound by its fissures, in the transverse plane (A), coronal plane (B) and sagittal plane (C).

CT scan showing upper lobe COVID-19, bound by its fissures, in the transverse plane (A), coronal plane (B) and sagittal plane (C). CT imaging has become an important tool in the evaluation of patients with COVID-19. Typical hallmarks of this infection include bilateral, multifocal, lower lobe and posterior-dominant ground-glass opacities and crazy-paving appearance.1 Lower lobe involvement can be seen in 90% of patients, while 86% present bilateral lesions.2 Amorphous patchy, nodular, patchy-nodular and rounded lesions are also commonly found.3 Additionally, more extensive lung involvement with opacification is associated with dyspnoea and a more severe course of COVID-19.4 Isolated upper lobe involvement is infrequent and is more frequently found in early stages of the disease.1 Moreover, haemoptysis is a rare symptom, reported in less than 5%5 of cases, usually associated with a more severe clinical course.6 We present a case of isolated right upper lobe involvement that is well limited by its fissure. Several patients can present with atypical imagiological findings. Isolated upper lobe involvement is a possible, although infrequent, presentation of COVID-19. Haemoptysis is a rare presentation of COVID-19.
  6 in total

1.  Atypical chest CT findings of COVID-19 pneumonia: a pictorial review.

Authors:  Naim Ceylan; Akın Çinkooğlu; Selen Bayraktaroğlu; Recep Savaş
Journal:  Diagn Interv Radiol       Date:  2021-05       Impact factor: 2.630

2.  A systematic review of clinical and laboratory parameters of 3,000 COVID-19 cases.

Authors:  Harsh Goel; Ishan Gupta; Meenakshi Mourya; Sukhdeep Gill; Anita Chopra; Amar Ranjan; Goura Kishor Rath; Pranay Tanwar
Journal:  Obstet Gynecol Sci       Date:  2021-01-27

3.  Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia.

Authors:  Fengxiang Song; Nannan Shi; Fei Shan; Zhiyong Zhang; Jie Shen; Hongzhou Lu; Yun Ling; Yebin Jiang; Yuxin Shi
Journal:  Radiology       Date:  2020-02-06       Impact factor: 11.105

4.  Lobar Distribution of COVID-19 Pneumonia Based on Chest Computed Tomography Findings; A Retrospective Study.

Authors:  Sara Haseli; Nastaran Khalili; Mehrdad Bakhshayeshkaram; Morteza Sanei Taheri; Yashar Moharramzad
Journal:  Arch Acad Emerg Med       Date:  2020-04-18

5.  Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis.

Authors:  Xiaobo He; Xiao Cheng; Xudong Feng; Hong Wan; Sihan Chen; Maoming Xiong
Journal:  Front Public Health       Date:  2021-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.